Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126690031 | 12669003 | 1 | I | 2016 | 20160812 | 20160819 | 20160819 | EXP | JP-SA-2016SA149441 | AVENTIS | 81.00 | YR | E | F | Y | 37.00000 | KG | 20160819 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126690031 | 12669003 | 1 | PS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | U | UNKNOWN | 20839 | 50 | MG | QD | ||||||
| 126690031 | 12669003 | 2 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 0 | |||||||||||
| 126690031 | 12669003 | 3 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | 0 | |||||||||||
| 126690031 | 12669003 | 4 | C | ALOSENN | SENNA LEAF | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126690031 | 12669003 | 1 | Cerebral disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126690031 | 12669003 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126690031 | 12669003 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |